Equity Residential (NYSE:EQR) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on EQR with a ...

Gaming and Leisure Properties, Inc. (NASDAQ:GLPI) is one of the most undervalued stocks. On June 5, Stifel analysts ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...

Zoetis Inc. (NYSE:ZTS) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, Stifel ...

Oracle (ORCL) shares rose more than 6% on Monday after CEO Safra Catz touted a "strong start" to fiscal 2026 and investment ...

TKO: “The Kilcoyne Opinion” is repping former Cardinals manager Tony LaRussa. The two champion skipper is bringing back many ...

According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.25%, which ...

Piper Sandler and Stifel Financial on Wednesday asked a judge to free them from "onerous" restrictions from the U.S.

The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for ...

Oracle Corp (NYSE:ORCL) shares are hitting new highs on Monday after the company's CEO provided bullish commentary on the ...

Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ:VTGN) with an unchanged price target of $12.00 post the company’s fiscal 2025 announcement.